244 results
Page 7 of 13
8-K
tlq60x 4t
7 Mar 12
Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) for Prevention of Respiratory Distress Syndrome
12:00am
8-K
EX-99.1
okh1gv81wo7a5lki2d1
8 Feb 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
l0l8llx37dhd2ra7cj
2 Feb 12
Other Events
12:00am
424B5
k06l6 2phlprgn
15 Dec 11
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
8b7w7f
28 Sep 11
Other Events
12:00am
8-K
vgh5t
29 Jul 11
Other Events
12:00am
8-K
EX-99.1
wci590ulg
29 Jul 11
Other Events
12:00am
8-K
EX-99.1
mr74b8wtg
1 Jun 11
Other Events
12:00am
424B5
hehh7x2t
17 Feb 11
Prospectus supplement for primary offering
12:00am
424B5
k31u1
15 Feb 11
Prospectus supplement for primary offering
12:00am
CORRESP
re5pb1ancr1mdvo46bs
10 Nov 10
Correspondence with SEC
12:00am
CORRESP
oslzv2ey 740
8 Nov 10
Correspondence with SEC
12:00am